This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q76194401
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunetu de 1952 im Juli 1952 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в липні 1952 scientific article published on 01 July 1952 wetenschappelijk artikel 1952 թվականի հուլիսի 1-ին հրատարակված գիտական հոդված
p:P577
wds:Q76194401-77D826C8-C09A-4C32-91AE-99350C82B329
wdt:P577
1952-07-01T00:00:00Z
p:P2093
wds:Q76194401-05548A8F-FD10-406E-B8E6-171603256B17 wds:Q76194401-8345C4E8-C586-4E7D-89D7-8C4EFF401353 wds:Q76194401-C7CDE787-B29B-49C5-A840-B06FB00D3D46 wds:Q76194401-A6495930-EFF7-4100-BA99-621FE57EF605
wdt:P2093
WELLMAN WE GERACI JE HERRELL WE HEILMAN FR
rdfs:label
Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin) Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin)
skos:prefLabel
Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin) Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin)
schema:name
Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin) Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin)
p:P1476
wds:Q76194401-A73173D4-027B-4BE6-A3D4-1F557D9AED20
wdt:P1476
Some laboratory and clinical observations on a new antibiotic, erythromycin (ilotycin)
p:P304
wds:Q76194401-69C92720-6E1C-4A88-B1C8-0965FE15AE9D
wdt:P304
285-304
p:P31
wds:Q76194401-E3DDCC98-49B4-443F-995E-08B0F7B6D438
wdt:P31
wd:Q13442814
p:P921
wds:Q76194401-D4E606EB-2100-4776-B0EE-40D2355BEB64
wdt:P921
wd:Q213511
p:P698
wds:Q76194401-5AD9BF8F-5AD9-4500-A413-D1F0613E7B78
wdtn:P698
n8:14941877
wdt:P698
14941877
p:P1433
wds:Q76194401-7B6CF930-CA71-4932-9810-DDDBB9AA5FD7
wdt:P1433
wd:Q27721232
p:P433
wds:Q76194401-F53F6A40-9318-445D-A635-3E5E075B4F82
p:P478
wds:Q76194401-6A079A23-5F9F-4A87-ABA5-EAC1EC1E129A
wdt:P433
15
wdt:P478
27